1Nakeeb A,Pitt HA,Sohn TA,et al. Cholangiocarcinoma:a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg, 1996,224(4) :463-473.
2Allema JH, Reinders ME, van Gulik TM, et al. Prognostic factor for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer, 1995,75 ( 8 ) :2069-2076.
3Takao S, Shinchi H, Uchikura K, et al. Liver metastasis after curative resection in patients with distal bile duct cancer. Br J Surg, 1999,86(3) :327-331.
4Takanori Y, Toshifumi M, Atsumoto, et al. Prognostic factor after pancreaticoduodenectomy with extended lymphadenectomy for distal bile duct cancer, Arch Surg,2002,137( 1 ) :69-73.
5Todoroki T, Kawamoto T, Koike N, et al. Treatment strategy for patients with middle and lower third bile duct cancer. Br J Surg,2001,88(3) :364-370.
6Ishikawa O, Ohigashi H, Sasaki Y, et al. Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surg, 1994,168 (4) :361-364.
7Nakai T,Koh K,Kawabe T,et al. Importance of microporinural invasion as a prognostic factor in ampullary carcinoma. Br J Surg, 1997,84(10) : 1393-1401.
8Bottger TC, Boddin J, Heintz A, et al. Clinicopathologic study for the assessment of resection for ampullary carcinoma, World J Surg,1997,21 (4) :379-383.
9Takanori Y,Toshifumi M,Atsumoto,et al.Prognostic factor after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer.Arch Surg,2002,137:69-73.
10Todoroki T,Kawamoto T,koike N ,et al.Treatment strategy for patients with middle and lower third bile duct cancer .Br J Surg,2001,88:364-370.
